Related references
Note: Only part of the references are listed.Monocyte derived dendritic cells generated by IFN-α acquire mature dendritic and natural killer cell properties as shown by gene expression analysis
Mark Korthals et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens
Caterina Lapenta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
IFN-α promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4
Marc Dauer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cell biology of antigen processing in vitro and in vivo
ES Trombetta et al.
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Dendritic cell biology and cancer therapy
TL Whiteside et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment
L Gabriele et al.
BLOOD (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Dendritic cells generated in the presence of interferon-α stimulate allogeneic CD4+ T-cell proliferation:: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells
C Carbonneil et al.
INTERNATIONAL IMMUNOLOGY (2004)
Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors
M Dauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Interferon-alpha in tumor immunity and immunotherapy
F Belardelli et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Cytokines as a link between innate and adaptive antitumor immunity
F Belardelli et al.
TRENDS IN IMMUNOLOGY (2002)
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment
M Mohty et al.
BLOOD (2001)
Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo
A Le Bon et al.
IMMUNITY (2001)
Share Paper
